1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 640 F.Supp.2d
  5. 640 F.Supp.2d 553 (2009)
 

ABRAXIS BIOSCIENCE, INC. v. NAVINTA, LLC

Civil Action No. 07-1251 (JAP).

640 F.Supp.2d 553 (2009)

ABRAXIS BIOSCIENCE, INC., Plaintiff, v. NAVINTA, LLC, Defendant.

United States District Court, D. New Jersey.

August 3, 2009.

Attorney(s) appearing for the Case

Michael R. Griffinger, Sheila F. McShane, Anthony M. Gruppuso, Gibbons, PC, Newark, NJ, for Plaintiff.

Christina Lynn Saveriano, Eric I. Abraham, Hill Wallack, LLP, Princeton, NJ, for Defendant.

OPINION

PISANO, District Judge.

This patent infringement action arises out of the filing of an Abbreviated New Drug Application ("ANDA") by Navinta, LLC ("Navinta"), a generic drug manufacturer, to market a generic version of an injectable form of the anesthetic Naropin. Naropin is indicated for the production of local or regional anesthesia for surgery and for acute pain management. Plaintiffs, Abraxis Bioscience, Inc. ("Abraxis") and APP Pharmaceuticals...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases